Literature DB >> 27197183

miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression.

Anna Guinot1, Feride Oeztuerk-Winder1, Juan-Jose Ventura2.   

Abstract

Defining the molecular and cellular roots of lung cancer relapse after initial treatment remains an imperative to improve survival. Here we report that the lung stem cell marker Lgr6 becomes enriched in non-small cell lung cancer (NSCLC) cells during malignant progression. Lgr6(+) NSCLC cells displayed self-renewal and differentiation properties along with a higher tumorigenic potential. Mechanistic investigations suggested that a defective repression of the miR-17-92 gene cluster was responsible for evolution of a selection for outgrowth of Lgr6(+) NSCLC cells. High levels of expression of miR-19 family members were found to target and downregulate levels of p38α kinase, providing a specific survival signal for Lgr6(+) cells as mediated by increased Wnt/ß-catenin activity. Our results identify a specific stem-like cell population in NSCLC with increased malignant potential, the elucidation of which may enable earlier prognosis and possibly the development of more effective targeted treatments. Cancer Res; 76(13); 4012-22. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197183     DOI: 10.1158/0008-5472.CAN-15-3302

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.

Authors:  Yuhei Kinehara; Izumi Nagatomo; Shohei Koyama; Daisuke Ito; Satoshi Nojima; Ryota Kurebayashi; Yoshimitsu Nakanishi; Yasuhiko Suga; Yu Nishijima-Futami; Akio Osa; Takeshi Nakatani; Yasuhiro Kato; Masayuki Nishide; Yoshitomo Hayama; Masayoshi Higashiguchi; Osamu Morimura; Kotaro Miyake; Sujin Kang; Toshiyuki Minami; Haruhiko Hirata; Kota Iwahori; Takayuki Takimoto; Hyota Takamatsu; Yoshito Takeda; Naoki Hosen; Shigenori Hoshino; Yasushi Shintani; Meinoshin Okumura; Toru Kumagai; Kazumi Nishino; Fumio Imamura; Shin-Ichi Nakatsuka; Takashi Kijima; Hiroshi Kida; Atsushi Kumanogoh
Journal:  JCI Insight       Date:  2018-12-20

2.  Increased miR-21a provides metabolic advantages through suppression of FBP1 expression in non-small cell lung cancer cells.

Authors:  Qingchun Dai; Na Li; Xiaohong Zhou
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 3.  Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.

Authors:  Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

4.  Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.

Authors:  Zhao Huang; Nan Ma; Yan-Lu Xiong; Lei Wang; Wei-Miao Li; Yuan-Yang Lai; Chen-Xi Zhang; Zhi-Pei Zhang; Xiao-Fei Li; Jin-Bo Zhao
Journal:  Onco Targets Ther       Date:  2019-11-27       Impact factor: 4.147

5.  Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.

Authors:  Nemanja Despot Marjanovic; Matan Hofree; Jason E Chan; David Canner; Katherine Wu; Marianna Trakala; Griffin G Hartmann; Olivia C Smith; Jonathan Y Kim; Kelly Victoria Evans; Anna Hudson; Orr Ashenberg; Caroline B M Porter; Alborz Bejnood; Ayshwarya Subramanian; Kenneth Pitter; Yan Yan; Toni Delorey; Devan R Phillips; Nisargbhai Shah; Ojasvi Chaudhary; Alexander Tsankov; Travis Hollmann; Natasha Rekhtman; Pierre P Massion; John T Poirier; Linas Mazutis; Ruifang Li; Joo-Hyeon Lee; Angelika Amon; Charles M Rudin; Tyler Jacks; Aviv Regev; Tuomas Tammela
Journal:  Cancer Cell       Date:  2020-07-23       Impact factor: 31.743

Review 6.  Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.

Authors:  Feifei Liu; Feng Zhang; Xiangyu Li; Qi Liu; Wei Liu; Peng Song; Ziying Qiu; Yu Dong; Hao Xiang
Journal:  Oncotarget       Date:  2017-07-08

Review 7.  WNT signaling - lung cancer is no exception.

Authors:  Judit Rapp; Luca Jaromi; Krisztian Kvell; Gyorgy Miskei; Judit E Pongracz
Journal:  Respir Res       Date:  2017-09-05

8.  MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.

Authors:  Brian Quattrochi; Anushree Gulvady; David R Driscoll; Makoto Sano; David S Klimstra; Christopher E Turner; Brian C Lewis
Journal:  Oncotarget       Date:  2017-05-30

9.  Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.

Authors:  Yuanyuan Gu; Shuoxin Liu; Xiaodan Zhang; Guimin Chen; Hongwei Liang; Mengchao Yu; Zhicong Liao; Yong Zhou; Chen-Yu Zhang; Tao Wang; Chen Wang; Junfeng Zhang; Xi Chen
Journal:  Protein Cell       Date:  2017-03-31       Impact factor: 14.870

10.  miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor.

Authors:  Wei Ma; Weiye Feng; Jie Tan; Airu Xu; Yudong Hu; Lanlan Ning; Yanhong Kang; Liuqian Wang; Ziwen Zhao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.